Back
Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Buy
56
PSTV
Plus Therapeutics
Last Price:
2.18
Seasonality Move:
-12.2%
Buy
62
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Buy
56
Plus Therapeutics (PSTV)
is a Buy
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $2.32. The Score for PSTV is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PSTV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.57. The Score for CATX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $2.32
The current trend is moderately bullish and PSTV is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.57
The current trend is moderately bearish and CATX is experiencing slight selling pressure.
PSTV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 72.44 | Buy |
| Chaikin Money Flow: | 4723 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.64 - 2.1) | Buy |
| Bollinger Bands (100): | (1.75 - 2.07) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -2625462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.63 - 1.51) | Buy |
PSTV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.18 | Buy |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.84 | Buy |
| 200-day SMA: | 1.86 | Buy |
| 8-day EMA: | 2.15 | Buy |
| 20-day EMA: | 1.99 | Buy |
| 50-day EMA: | 1.91 | Buy |
| 200-day EMA: | 2.31 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.76 | Sell |
| 20-day SMA: | 1.68 | Sell |
| 50-day SMA: | 1.44 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.71 | Sell |
| 20-day EMA: | 1.67 | Sell |
| 50-day EMA: | 1.45 | Buy |
| 200-day EMA: | 0.89 | Buy |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.05 per share, an increase this year of $2.46 per share, and an increase next year of $0.02 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Plus Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||